Simbol RGEN | |
Simbol | RGEN |
Simbol eToro | RGEN |
MarketWatch | RGEN |
Finviz | RGEN |
Yahoo Finance | RGEN |
Google Finance | RGEN |
TradingView | RGEN |
Investing.com | RGEN |
Wikipedia | Repligen |
Denumire | Repligen Corp. |
Website | repligen.com |
Piața | NASDAQ |
ISIN | US7599161095 |
Sector | Health Technology |
Industrie | Pharmaceuticals Major |
Monedă | USD |
Preț | 157,4600 USD |
Capitalizare bursieră | 8,770 mld. USD |
P/E | 53,51 |
Beta | 1,3514 |
EPS | 2,9428 |
Profit anual | +10,36% |
Dată actualizare | 16.06.2023 |
Descriere |
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
02.09.2021 | 160,05 | 0,8569 | 15,720 | 0,00% | 0,0000 | +84,80% | $0,00 |
05.12.2022 | 64,44 | 0,9554 | 10,330 | 0,00% | 2,8870 | -27,92% | $178,31 |
07.12.2022 | 58,58 | 0,9578 | 9,390 | 0,00% | 2,8870 | -34,65% | $169,13 |
16.06.2023 | 53,51 | 1,3514 | 8,770 | 0,00% | 2,9428 | +10,36% | $157,46 |